WHO’s Big Move on Weight-Loss Meds

The WHO is about to officially back weight-loss drugs like Wegovy and Zepbound for adults battling obesity—huge news since over a billion people worldwide are affected. But here’s the catch: these meds can cost over $1,000 a month and might need to be taken for life. WHO’s also pushing for ways to make them more affordable, especially in lower-income countries, and is considering adding them to its essential medicines list. Cheaper generics could be coming soon! #weightloss #WHO #healthnews #obesity #medications #pharma #Health